GGrantIndex
← Search

Durvalumab in Combination with Olaparib in Non-Small Cell Lung Cancer

$129,604ZIAFY2020CANIH

Division Of Basic Sciences - Nci

Investigators

Linked publications, trials & patents

View original record on NIH RePORTER →
Durvalumab in Combination with Olaparib in Non-Small Cell Lung Cancer · GrantIndex